Reckitt Benckiser Group plc (LON:RKT – Get Free Report) insider Kris Licht sold 10,344 shares of the business’s stock in a transaction dated Thursday, May 2nd. The stock was sold at an average price of GBX 4,479 ($56.26), for a total transaction of £463,307.76 ($581,971.81).
Reckitt Benckiser Group Stock Performance
LON RKT traded up GBX 7.27 ($0.09) during trading hours on Friday, reaching GBX 4,476.27 ($56.23). The stock had a trading volume of 3,336,601 shares, compared to its average volume of 2,098,938. The stock has a fifty day moving average of GBX 4,617.97 and a 200 day moving average of GBX 5,236.89. The stock has a market cap of £31.71 billion, a P/E ratio of 1,973.57, a price-to-earnings-growth ratio of 3.76 and a beta of 0.07. Reckitt Benckiser Group plc has a 52-week low of GBX 4,102.64 ($51.53) and a 52-week high of GBX 6,570 ($82.53). The company has a debt-to-equity ratio of 100.80, a quick ratio of 0.46 and a current ratio of 0.64.
Reckitt Benckiser Group Increases Dividend
The business also recently disclosed a dividend, which will be paid on Friday, May 24th. Shareholders of record on Thursday, April 11th will be given a GBX 115.90 ($1.46) dividend. This represents a yield of 1.99%. The ex-dividend date of this dividend is Thursday, April 11th. This is a positive change from Reckitt Benckiser Group’s previous dividend of $76.60. Reckitt Benckiser Group’s dividend payout ratio is currently 8,502.20%.
Analyst Upgrades and Downgrades
View Our Latest Analysis on Reckitt Benckiser Group
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
See Also
- Five stocks we like better than Reckitt Benckiser Group
- 5 discounted opportunities for dividend growth investors
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- What Does Downgrade Mean in Investing?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- How Investors Can Find the Best Cheap Dividend Stocks
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.